bf/NASDAQ:LUNG_icon.jpeg

NASDAQ:LUNG

Pulmonx

  • Stock

USD

Last Close

1.81

06/11 22:07

Market Cap

246.48M

Beta: 0.32

Volume Today

1.55M

Avg: 503.90K

PE Ratio

−8.91

PFCF: −17.91

    Description

    Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console syst...Show More

    Earnings

    Earnings per Share (Estimate*)

    -5-4-3-2-12019-03-302020-06-292022-05-032024-02-212024-11-042025-10-28

    Revenue (Estimate*)

    10M20M30M40M50M60M70M2019-03-302020-06-292022-05-032024-02-212024-11-042025-10-28

    *Estimate based on analyst consensus